Researchers have shown that physical therapy for carpal tunnel syndrome is just as good as carpal tunnel surgery. The researchers report that 1 year after treatment, individuals having carpal tunnel syndrome that had been given physical therapy experienced results equivalent to those for individuals who had carpal tunnel surgery. Individuals who had received physical therapy… Read More »
As the number of U.S. spinal muscular atrophy (SMA) patients Zolgensma treats each quarter stabilizes, Novartis is counting on a set of “inflection points” for future growth. Now, it has one. After a manufacturing-related delay, Novartis has won conditional approval in the EU for the one-time gene therapy to treat patients with a clinical diagnosis… Read More »
As the COVID-19 pandemic swells, experts around the globe are working to determine which existing medicines might help patients experiencing severe illness. Malaria drug chloroquine has gotten a lot of the attention, but now a team suggests a Roche stroke drug is worth exploring. In an article in the Journal of Trauma and Acute Care Surgery, authors wrote that tissue plasminogen activator, or… Read More »
In a few short weeks, the novel coronavirus pandemic has upturned countries around the world, presenting new and complex workplace challenges. That shift is also true for drugmakers working to combat COVID-19. For New York-based Regeneron––at the forefront of the COVID-19 hunt––those challenges are unprecedented and extraordinary, but it’s still mostly business as usual. After… Read More »